These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 22408034)
1. Effects of celecoxib on restenosis after coronary intervention and evolution of atherosclerosis (Mini-COREA) trial: celecoxib, a double-edged sword for patients with angina. Kang HJ; Oh IY; Chung JW; Yang HM; Suh JW; Park KW; Kwon TK; Lee HY; Cho YS; Youn TJ; Koo BK; Kang WY; Kim W; Rha SW; Bae JH; Chae IH; Choi DJ; Kim HS Eur Heart J; 2012 Nov; 33(21):2653-61. PubMed ID: 22408034 [TBL] [Abstract][Full Text] [Related]
2. Long-term outcome of adjunctive celecoxib treatment after paclitaxel-eluting stent implantation for the complex coronary lesions: two-year clinical follow-up of COREA-TAXUS trial. Chung JW; Yang HM; Park KW; Lee HY; Park JS; Kang HJ; Cho YS; Youn TJ; Koo BK; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS Circ Cardiovasc Interv; 2010 Jun; 3(3):243-8. PubMed ID: 20484099 [TBL] [Abstract][Full Text] [Related]
3. Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study. Koo BK; Kim YS; Park KW; Yang HM; Kwon DA; Chung JW; Hahn JY; Lee HY; Park JS; Kang HJ; Cho YS; Youn TJ; Chung WY; Chae IH; Choi DJ; Oh BH; Park YB; Kim HS Lancet; 2007 Aug; 370(9587):567-74. PubMed ID: 17707751 [TBL] [Abstract][Full Text] [Related]
4. A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents. Byrne RA; Mehilli J; Iijima R; Schulz S; Pache J; Seyfarth M; Schömig A; Kastrati A Eur Heart J; 2009 Apr; 30(8):923-31. PubMed ID: 19240066 [TBL] [Abstract][Full Text] [Related]
5. Comparison of zotarolimus-eluting stents versus sirolimus-eluting stents versus paclitaxel-eluting stents for primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: results from the Korean Multicentre Endeavor (KOMER) acute myocardial infarction (AMI) trial. Kang WC; Ahn T; Lee K; Han SH; Shin EK; Jeong MH; Yoon JH; Park JS; Bae JH; Hur SH; Rha SW; Oh SK; Kim DI; Jang Y; Choi JW; Kim BO EuroIntervention; 2011 Dec; 7(8):936-43. PubMed ID: 21959255 [TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Stone GW; Midei M; Newman W; Sanz M; Hermiller JB; Williams J; Farhat N; Caputo R; Xenopoulos N; Applegate R; Gordon P; White RM; Sudhir K; Cutlip DE; Petersen JL; Circulation; 2009 Feb; 119(5):680-6. PubMed ID: 19171853 [TBL] [Abstract][Full Text] [Related]
7. Randomized trial of optimal treatment strategies for in-stent restenosis after drug-eluting stent implantation. Song HG; Park DW; Kim YH; Ahn JM; Kim WJ; Lee JY; Kang SJ; Lee SW; Lee CW; Park SW; Han S; Seong IW; Lee NH; Lee BK; Lee K; Lee SW; Nah DY; Park SJ J Am Coll Cardiol; 2012 Mar; 59(12):1093-100. PubMed ID: 22421303 [TBL] [Abstract][Full Text] [Related]
8. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Bangalore S; Kumar S; Fusaro M; Amoroso N; Attubato MJ; Feit F; Bhatt DL; Slater J Circulation; 2012 Jun; 125(23):2873-91. PubMed ID: 22586281 [TBL] [Abstract][Full Text] [Related]
9. A prospective multicenter parallel-controlled trial of TIVOLI biodegradable-polymer-based sirolimus-eluting stent compared to ENDEAVOR zotarolimus-eluting stent for the treatment of coronary artery disease: 8-month angiographic and 2-year clinical follow-up results. Xu B; Dou KF; Han YL; Lü SZ; Yang YJ; Huo Y; Wang LF; Chen YD; Wang HC; Li WM; Chen JY; Wang L; Wang Y; Ge JB; Li W; Gao RL Chin Med J (Engl); 2011 Mar; 124(6):811-6. PubMed ID: 21518585 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. Lee CW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Yun SC; Seong IW; Lee JH; Lee NH; Cho YH; Cheong SS; Lim DS; Yang JY; Lee SG; Kim KS; Yoon J; Jeong MH; Seung KB; Hong TJ; Park SJ; Am J Cardiol; 2009 Nov; 104(10):1370-6. PubMed ID: 19892052 [TBL] [Abstract][Full Text] [Related]
11. A randomized, prospective, two-center comparison of sirolimus-eluting stent and zotarolimus-eluting stent in acute ST-elevation myocardial infarction: the SEZE trial. Chung WY; Kang J; Cho YS; Park HJ; Yang HM; Seo JB; Suh JW; Kim KI; Youn TJ; Kim SH; Chae IH; Zo JH; Kim MA; Choi DJ Chin Med J (Engl); 2012 Oct; 125(19):3373-81. PubMed ID: 23044291 [TBL] [Abstract][Full Text] [Related]
12. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. Rittger H; Brachmann J; Sinha AM; Waliszewski M; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Breithardt OA; Schmidt M; Zimmermann S; Lonke S; von Cranach M; Nguyen TV; Daniel WG; Wöhrle J J Am Coll Cardiol; 2012 Apr; 59(15):1377-82. PubMed ID: 22386286 [TBL] [Abstract][Full Text] [Related]
13. Drug-eluting stent for the treatment of small coronary lesion: comparison between sirolimus- and paclitaxel-eluting stent. Li JJ; Xu B; Yang YJ; Chen JL; Qiao SB; Ma WH; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL Chin Med J (Engl); 2007 Apr; 120(7):569-73. PubMed ID: 17442204 [TBL] [Abstract][Full Text] [Related]
14. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study. Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy of polymer-based paclitaxel-eluting stents in the treatment of complex, long coronary artery lesions from a multicenter, randomized trial: support for the use of drug-eluting stents in contemporary clinical practice. Dawkins KD; Grube E; Guagliumi G; Banning AP; Zmudka K; Colombo A; Thuesen L; Hauptman K; Marco J; Wijns W; Popma JJ; Koglin J; Russell ME; Circulation; 2005 Nov; 112(21):3306-13. PubMed ID: 16286586 [TBL] [Abstract][Full Text] [Related]
16. Celecoxib and hypertension-insights from the effect of celecoxib on restenosis after coronary angioplasty with a taxus stent trial. Bangalore S; Khianey S; Messerli FH Am J Cardiol; 2008 Apr; 101(7):1068. PubMed ID: 18359335 [No Abstract] [Full Text] [Related]
17. Outcomes of paclitaxel-eluting stent implantation in patients with stenosis of the left anterior descending coronary artery. Dangas G; Ellis SG; Shlofmitz R; Katz S; Fish D; Martin S; Mehran R; Russell ME; Stone GW; J Am Coll Cardiol; 2005 Apr; 45(8):1186-92. PubMed ID: 15837247 [TBL] [Abstract][Full Text] [Related]
18. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents. Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841 [TBL] [Abstract][Full Text] [Related]